tiprankstipranks
Instadose Pharma (INSD)
OTHER OTC:INSD
US Market
INSD
Instadose Pharma
RESEARCH TOOLSreports

Instadose Pharma (INSD) Ratios

18 Followers

Instadose Pharma Ratios

INSD's free cash flow for Q1 2022 was $0.00. For the 2022 fiscal year, INSD's free cash flow was decreased by $ and operating cash flow was $0.00. See a summary of the company’s cash flow.
Ratios
TTM
Nov 21Nov 20Nov 19Nov 18
Liquidity Ratios
Current Ratio
 0.00 0.00 <0.01 <0.01 <0.01
Quick Ratio
 0.00 0.00 <0.01 <0.01 <0.01
Cash Ratio
 0.00 0.00 <0.01 <0.01 <0.01
Solvency Ratio
 -1.79 -1.79 -0.07 -0.43 -0.70
Operating Cash Flow Ratio
 >-0.01 >-0.01 >-0.01 <0.01 -0.09
Short-Term Operating Cash Flow Coverage
 0.00 0.00 0.00 <0.01 0.00
Net Current Asset Value
$ -127.02K$ -127.02K$ -206.71K$ -106.94K$ -44.38K
Leverage Ratios
Debt-to-Assets Ratio
 0.00 0.00 0.00 659.54 246.51
Debt-to-Equity Ratio
 0.00 0.00 0.00 -0.57 -0.74
Debt-to-Capital Ratio
 0.00 0.00 0.00 -1.33 -2.81
Long-Term Debt-to-Capital Ratio
 0.00 0.00 0.00 0.00 0.00
Financial Leverage Ratio
 -0.02 -0.02 >-0.01 >-0.01 >-0.01
Debt Service Coverage Ratio
 0.00 0.00 0.00 -0.42 0.00
Interest Coverage Ratio
 0.00 0.00 0.00 0.00 0.00
Debt to Market Cap
 0.00 0.00 0.00 <0.01 0.00
Interest Debt Per Share
 0.00 0.00 0.00 <0.01 <0.01
Net Debt to EBITDA
 0.00 0.00 0.01 -2.39 -1.04
Profitability Margins
Gross Profit Margin
0.00%0.00%0.00%0.00%49.13%
EBIT Margin
0.00%0.00%0.00%0.00%-867.03%
EBITDA Margin
0.00%0.00%0.00%0.00%-867.03%
Operating Profit Margin
0.00%0.00%0.00%0.00%-653.01%
Pretax Profit Margin
0.00%0.00%0.00%0.00%-867.03%
Net Profit Margin
0.00%0.00%0.00%0.00%-867.03%
Continuous Operations Profit Margin
0.00%0.00%0.00%0.00%-867.03%
Net Income Per EBT
127.48%127.48%129.84%165.78%100.00%
EBT Per EBIT
100.00%100.00%100.00%100.00%132.78%
Return on Assets (ROA)
-19633.33%-19633.33%-39471.34%-45713.20%-23540.00%
Return on Equity (ROE)
503.52%463.72%31.15%39.56%70.42%
Return on Capital Employed (ROCE)
372.55%372.55%12.41%30.92%53.04%
Return on Invested Capital (ROIC)
372.55%372.55%12.41%118.74%53.04%
Return on Tangible Assets
-19633.33%-19633.33%-39471.34%-45713.20%-23540.00%
Earnings Yield
-7853.33%-0.03%-0.45%-0.52%-0.42%
Efficiency Ratios
Receivables Turnover
 0.00 0.00 0.00 0.00 0.00
Payables Turnover
 0.00 0.00 0.00 0.00 1.73
Inventory Turnover
 0.00 0.00 0.00 0.00 0.00
Fixed Asset Turnover
 0.00 0.00 0.00 0.00 0.00
Asset Turnover
 0.00 0.00 0.00 0.00 27.15
Working Capital Turnover Ratio
 0.00 0.00 0.00 0.00 -0.12
Cash Conversion Cycle
 0.00 0.00 0.00 0.00 -210.65
Days of Sales Outstanding
 0.00 0.00 0.00 0.00 0.00
Days of Inventory Outstanding
 0.00 0.00 0.00 0.00 0.00
Days of Payables Outstanding
 0.00 0.00 0.00 0.00 210.65
Operating Cycle
 0.00 0.00 0.00 0.00 0.00
Cash Flow Ratios
Operating Cash Flow Per Share
 >-0.01 >-0.01 >-0.01 <0.01 >-0.01
Free Cash Flow Per Share
 >-0.01 >-0.01 >-0.01 <0.01 >-0.01
CapEx Per Share
 0.00 0.00 0.00 0.00 0.00
Free Cash Flow to Operating Cash Flow
 1.00 1.00 1.00 1.00 1.00
Dividend Paid and CapEx Coverage Ratio
 0.00 0.00 0.00 0.00 0.00
Capital Expenditure Coverage Ratio
 0.00 0.00 0.00 0.00 0.00
Operating Cash Flow Coverage Ratio
 0.00 0.00 0.00 <0.01 -0.13
Operating Cash Flow to Sales Ratio
 0.00 0.00 0.00 0.00 -1.15
Free Cash Flow Yield
-0.16%>-0.01%>-0.01%<0.01%-0.06%
Valuation Ratios
Price-to-Earnings (P/E) Ratio
 -0.02 -3.13K -221.76 -191.48 -236.36
Price-to-Sales (P/S) Ratio
 0.00 0.00 0.00 0.00 2.05K
Price-to-Book (P/B) Ratio
 -0.06 -14.53K -69.08 -75.75 -166.44
Price-to-Free Cash Flow (P/FCF) Ratio
 -642.24 -22.29M -89.20K 26.71K -1.78K
Price-to-Operating Cash Flow Ratio
 -90.55 -22.29M -89.20K 26.71K -1.78K
Price-to-Earnings Growth (PEG) Ratio
 <0.01 -2.09 5.54 -7.66 11.82
Price-to-Fair Value
 -0.06 -14.53K -69.08 -75.75 -166.44
Enterprise Value Multiple
 -0.53 -18.38K -1.26K -319.82 -237.40
Enterprise Value
 53.19K 1.85B 7.39M 7.44M 7.42M
EV to EBITDA
 -0.53 -18.38K -1.26K -319.82 -237.40
EV to Sales
 0.00 0.00 0.00 0.00 2.06K
EV to Free Cash Flow
 -642.24 -22.29M -89.19K 26.91K -1.79K
EV to Operating Cash Flow
 -642.24 -22.29M -89.19K 26.91K -1.79K
Tangible Book Value Per Share
 >-0.01 >-0.01 >-0.01 >-0.01 >-0.01
Shareholders’ Equity Per Share
 >-0.01 >-0.01 >-0.01 >-0.01 >-0.01
Tax and Other Ratios
Effective Tax Rate
 0.00 0.00 0.00 0.00 0.00
Revenue Per Share
 0.00 0.00 0.00 0.00 <0.01
Net Income Per Share
 >-0.01 >-0.01 >-0.01 >-0.01 >-0.01
Tax Burden
 1.27 1.27 1.30 1.66 1.00
Interest Burden
 1.00 1.00 1.00 1.00 1.00
Research & Development to Revenue
 0.00 0.00 0.00 0.00 0.00
SG&A to Revenue
 0.00 0.00 0.00 0.00 9.16
Stock-Based Compensation to Revenue
 0.00 0.00 0.00 0.00 0.00
Income Quality
 <0.01 <0.01 <0.01 >-0.01 0.13
Currency in USD